Reading Room Production — page 213

you have a ony sent me n detail to the [ should I reached out, ve mentioned oved to Richard thinks aying anything We have an overlapping s biodefense > you on MCMI re JJ > I would suggest to Richard that the meeting be "delayed" until you have a > better understanding of what Francis has in mind, yadda yadda. > > > -----Original Message----- From: Ranganathan, Rajesh (NIH/OD) [C] > Sent: Thursday, November 18, 2010 6:51 PM To: Hudson, Kathy (NIH/OD) [E] > Cc: Tabak, Lawrence (NIH/OD) [E] Subject: FW: Discussion about Cures Acceleration Network and the President's > Medical Countermeasures Initiative (MCMI) > Kathy: > Some background for you (I was able to tell Larry in person)..Tony sent me to JJ McGowan, who thought that Richard Hatchett, currently on detail to the > White House is someone I should talk to because he might have the skill set to help with NCTS. I checked in with Larry and we agreed that I should > certainly meet such people and hear them out. So, when Richard reached out, I agreed to go down to the EEOB to meet him. He appears to have mentioned > that he is meeting me to Ms. Heidi Avery (Deputy Homeland Security Adviser to the President), who now wants to join in and the meeting got moved to > Monday to accommodate her schedule. Please see below for what Richard thinks Ms. Avery wants to know. > Two issues: a) there is not much I can say about CAN or anything else re: > NCTS on Monday, and b) as a contractor, I should not be reprenseting the NIH externally. Larry has arranged from Robin from DPCPSI to go with me to > ensure that the NIH is represented by an employee. > But I am wondering if this meeting with Ms. Avery should even happen - feels too early in the process Please advise on the ramifications of > cancelling/postponing on her vs. taking the meeting and not saying anything substantive... Thanks. > Rajesh > ------ Forwarded Message > From: "Hatchett, Richard J." < @nss.eop.gov> Date: Thu, 18 Nov 2010 08:51:35 -0500 > To: "Ranganathan, Rajesh (NIH/OD) [C]" < @nih.gov> Subject: Re: Discussion about Cures Acceleration Network and the President's > Medical Countermeasures Initiative (MCMI) > Rajesh, > Sorry, I should have clarified that in our initial exchanges, as I assumed that was the context in which JJ spoke with you. We have an overlapping > (and in fact prior) interest in CAN because of the President's biodefense initiative, and I was taking advantage of JJ's intro to contact you on MCMI > (I hadn't heard that you'd been selected for the position before JJ contacted me). >